Search Results 1501-1510 of 17146 for monoclonal antibody
... antibodies. Prior therapy with any antibody or inhibitors targeting the TGF-β/TGF-β receptor pathway. Anticancer treatment within 21 days before the start ...
Subjects with positive hepatitis B virus core antibody are excluded only if they have concurrent negative hepatitis B surface antibody or detectable serum ...
... antibody therapy. Radiation therapy within 3 weeks prior to first dose. Radioimmunotherapy within 8 weeks prior to first dose. Localized radiation therapy ...
... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell costimulation or checkpoint pathways); Is pregnant or breast ...
The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...
... antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. Pagination Clinical studies. Prev ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
Immune globulin bovine is a medical food that is used for clinical dietary management of enteropathy (intestinal or bowel problems) in patients who have a ...
At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...
Has a history of positive or intermediate results for hepatitis B surface antigen, hepatitis B core antibody, or hepatitis C virus antibody at screening.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.